Cargando…
STW 5 (Iberogast(®))—a safe and effective standard in the treatment of functional gastrointestinal disorders
Functional dyspepsia (FD) and irritable bowel syndrome (IBS) are frequent disorders affecting quality of life. They often require long-term treatment. Abdominal symptoms of both disorders can overlap, making differential diagnosis and treatment challenging. The extracts of the herbal combination pre...
Autores principales: | Ottillinger, Bertram, Storr, Martin, Malfertheiner, Peter, Allescher, Hans-Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580135/ https://www.ncbi.nlm.nih.gov/pubmed/23263639 http://dx.doi.org/10.1007/s10354-012-0169-x |
Ejemplares similares
-
Modulation of gastrointestinal motility beyond metoclopramide and domperidone: Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders
por: Madisch, Ahmed, et al.
Publicado: (2017) -
Early onset of efficacy in patients with functional and motility-related gastrointestinal disorders: A noninterventional study with Iberogast®
por: Raedsch, Richard, et al.
Publicado: (2017) -
Rare manifestation of a large stenosing gastrointestinal tumor caused by Mycobacterium tuberculosis in a previously healthy man from Austria
por: Shao, Guangyu, et al.
Publicado: (2021) -
Viral entry pathways: the example of common cold viruses
por: Blaas, Dieter
Publicado: (2016) -
Evaluation of a rapid-antigen test for COVID-19 in an asymptomatic collective: A prospective study
por: von Ahnen, Thomas, et al.
Publicado: (2021)